China Medical GatewayLoading your healthcare gateway…

Bai Chun Xue

Bai Chun Xue — Chief Physician — Respiratory Medicine — Zhongshan Hospital affiliated with Fudan University

Specialties

1. Accurate differential diagnosis of pulmonary nodules: Using AI-assisted analysis technology to detect and diagnose the earliest stage of lung cancer in pulmonary nodules that are difficult to characterize, with a differential diagnosis accuracy of over 98%. Currently, a diagnostic database of more than 20,000 pulmonary nodules has been established; 2. Comprehensive treatment and intelligent management of early-stage lung cancer: Leading real-world studies to prevent recurrence and metastasis, benefiting many patients, with a ten-year survival rate and even a potential cure rate of over 90%. In order to detect and diagnose the earliest stage of lung cancer in pulmonary nodules that are difficult to characterize through AI-assisted analysis technology, thin-slice CT information in DICOM format is required, which should be sent in advance via Baidu Cloud link to the assistant.

Education

Professor Li Huade from Zhongshan Hospital in Shanghai pursued graduate studies and obtained a master's degree followed by a doctoral degree.

Professional Experience

Chief Physician, Professor at Zhongshan Hospital Affiliated to Fudan University, PhD and Postdoctoral Supervisor, Shanghai Leading Talent, Director of Shanghai Research Institute of Respiratory Diseases, Director of Shanghai Clinical Quality Control Center for Respiratory Medicine. Practicing medicine for 51 years, with the motto 'Establish oneself through academics, benefit the public as the foundation.' Professionally, he studied under Professor Zhu Guiqing and Professor Luo Weici at Peking Union Medical College Hospital, conducted graduate research under Professor Li Huade at Zhongshan Hospital, Shanghai, earned both master's and doctoral degrees, and later pursued postdoctoral research under the internationally renowned ARDS expert Michael Matthay at the University of California, San Francisco. After returning to China, he was the first globally to propose 'Internet of Medical Things Medicine' and 'Metaverse Medicine', led the 'Asia-Pacific Lung Nodule Assessment Guidelines', laying a solid foundation for the subsequent development of new technologies and the leadership in formulating consensus guidelines. Science popularization and public welfare: Professor Bai places great emphasis on science popularization and public welfare work. He proposed the vision of 'Famous doctors prevent disease, Metaverse medicine benefits all living beings,' and founded the 'Intelligent International Metaverse Medicine Association and Alliance' (iamm.org.cn), focusing on lung nodule patients, serving 150 million lung nodule patients in China, and promoting early detection, early diagnosis, and early treatment of lung cancer. Aiming to improve the ten-year survival rate and even achieve a cure, all medical staff are welcome to participate, assist patients in self-help and mutual aid, and organize members to carry out comprehensive secondary and tertiary prevention activities based on a psychological-social-biomedical model.

Professional Roles

Vice Chairman of the Chinese Medical Association Former Positions: Vice Chairman of the Chinese Medical Association and Vice President of the Respiratory Branch of the Chinese Medical Doctor Association Current Positions: President of the International Metaverse Medicine Association and Alliance, President of the China Lung Cancer Prevention and Treatment Alliance, President of the Shanghai Tobacco Control Association (Editor-in-chief of health-related popular science books "Questions on Health Care for Plateau Travel and Air Travel" and "Hand in Hand for Healthy Travel", wrote all respiratory chapters in "Family Medicine" and authored dozens of popular science articles.), President of the IoT Medical Branch of the China Non-Governmental Medical Institutions Association, Editor-in-chief of the journal "Clinical e-Health (Clinical IoT Medicine)", Respiratory Editor-in-Chief of Frontiers in Medicine, and editorial board member of AJRCCM, among others.

Return to Home